Most-Downgraded StocksMost-DowngradedNYSE:AGL agilon health (AGL) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free AGL Stock Alerts $6.10 +0.36 (+6.28%) (As of 03/28/2024 ET) Add Compare Share Share Today's Range$5.65▼$6.1650-Day Range$4.77▼$7.4552-Week Range$4.44▼$28.99Volume4.75 million shsAverage Volume6.21 million shsMarket Capitalization$2.50 billionP/E RatioN/ADividend YieldN/APrice Target$9.73 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get agilon health alerts: Email Address agilon health MarketRank™ Stock AnalysisAnalyst RatingHold2.19 Rating ScoreUpside/Downside59.7% Upside$9.73 Price TargetShort InterestBearish15.52% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.02Based on 27 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.35) to ($0.19) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.16 out of 5 starsMedical Sector570th out of 938 stocksMiscellaneous Health & Allied Services, Not Elsewhere Classified Industry5th out of 6 stocks 4.1 Analyst's Opinion Consensus Ratingagilon health has received a consensus rating of Hold. The company's average rating score is 2.19, and is based on 4 buy ratings, 11 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.73, agilon health has a forecasted upside of 59.7% from its current price of $6.10.Amount of Analyst Coverageagilon health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.0 Short Interest Percentage of Shares Shorted15.52% of the float of agilon health has been sold short.Short Interest Ratio / Days to Coveragilon health has a short interest ratio ("days to cover") of 8.Change versus previous monthShort interest in agilon health has recently decreased by 2.11%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend Yieldagilon health does not currently pay a dividend.Dividend Growthagilon health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AGL. Previous Next 2.8 News and Social Media Coverage News Sentimentagilon health has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 27 news articles for agilon health this week, compared to 4 articles on an average week.Search Interest14 people have searched for AGL on MarketBeat in the last 30 days. This is an increase of 40% compared to the previous 30 days.MarketBeat Follows7 people have added agilon health to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, agilon health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.60% of the stock of agilon health is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for agilon health are expected to grow in the coming year, from ($0.35) to ($0.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of agilon health is -9.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of agilon health is -9.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share Ratioagilon health has a P/B Ratio of 3.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About agilon health Stock (NYSE:AGL)agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.Read More AGL Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AGL Stock News HeadlinesMarch 28, 2024 | stockhouse.comKessler Topaz Meltzer & Check, LLP Has Filed a Securities Fraud Class Action Lawsuit Against Agilon Heatlh, Inc.March 28, 2024 | stockhouse.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in agilon health, inc. with Losses of $100,000 to Contact the FirmMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 28, 2024 | markets.businessinsider.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon healthMarch 28, 2024 | businesswire.comAGL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that agilon health, inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!March 28, 2024 | prnewswire.comAGL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that agilon health, inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!March 27, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGLMarch 27, 2024 | tmcnet.comThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of agilon health, inc. (AGL) InvestorsMarch 28, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 27, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of agilon health, inc. (AGL) InvestorsMarch 27, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of agilon health, inc.March 27, 2024 | prnewswire.comClass Action Filed Against agilon health, inc. (AGL) Seeking Recovery for Investors - Contact Levi & KorsinskyMarch 26, 2024 | prnewswire.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages agilon health, inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AGLMarch 26, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of agilon health, inc. (AGL) on Behalf of InvestorsMarch 26, 2024 | prnewswire.comagilon health, inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - AGLMarch 25, 2024 | stockhouse.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon healthMarch 25, 2024 | tmcnet.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of agilon health, inc. (AGL) on Behalf of InvestorsMarch 25, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of agilon health, inc.March 25, 2024 | businesswire.comInvestor Alert (NYSE: AGL): Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against agilon health, inc. With Expanded Class Period and Encourages Investors With Substantial Losses to Contact the FirmMarch 25, 2024 | businesswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – AGLMarch 25, 2024 | americanbankingnews.comagilon health, inc. (NYSE:AGL) Given Average Recommendation of "Hold" by BrokeragesMarch 24, 2024 | americanbankingnews.comagilon health (NYSE:AGL) Hits New 1-Year Low at $4.99March 22, 2024 | prnewswire.comAGILON HEALTH SHAREHOLDER ALERT: CLAIMSFILER Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against agilon health, inc. - AGLMarch 22, 2024 | businesswire.comagilon health, inc. (AGL) Stockholder Alert: Robbins LLP Reminds Investors of AGL Class ActionMarch 22, 2024 | prnewswire.comInvestor Alert: Investor Class Action Lawsuit Filed Against Agilon Health, Inc. (NYSE: AGL)March 22, 2024 | prnewswire.comInvestors in agilon health, inc. Should Contact The Gross Law Firm Before May 20, 2024 to Discuss Your Rights - AGLMarch 21, 2024 | stockhouse.comSHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against agilon health, inc. - AGLSee More Headlines Receive AGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for agilon health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/27/2024Today3/28/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNYSE:AGL CUSIPN/A CIK1831097 Webagilonhealth.com Phone562-256-3800FaxN/AEmployees1,117Year FoundedN/APrice Target and Rating Average Stock Price Target$9.73 High Stock Price Target$18.00 Low Stock Price Target$5.00 Potential Upside/Downside+59.5%Consensus RatingHold Rating Score (0-4)2.19 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)($0.65) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-262,600,000.00 Net Margins-5.76% Pretax Margin-4.51% Return on Equity-21.74% Return on Assets-8.89% Debt Debt-to-Equity Ratio0.05 Current Ratio1.51 Quick Ratio1.51 Sales & Book Value Annual Sales$4.32 billion Price / Sales0.58 Cash FlowN/A Price / Cash FlowN/A Book Value$1.63 per share Price / Book3.74Miscellaneous Outstanding Shares409,542,000Free Float394,798,000Market Cap$2.50 billion OptionableNot Optionable Beta0.49 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Steven Jackson Sell (Age 58)President, CEO & Director Comp: $1.29MMr. Timothy S. Bensley (Age 63)Chief Financial Officer Comp: $831.31kMr. Girish Venkatachaliah (Age 50)Chief Technology Officer Comp: $655.04kMr. Ben Shaker (Age 41)Chief Markets Officer Comp: $715.5kMr. Veeral Desai (Age 43)Chief Strategy & Development Officer Comp: $667.58kMr. Timothy Gertsch (Age 38)VP, Controller & Chief Accounting Officer Mr. Matthew Dale Gillmor CFAVice President of Investor RelationsMs. Denise ZamoreChief Legal Officer & SecretaryMs. Claire MulhearnChief Communications & Public Affairs OfficerMr. Mat VargheseChief People OfficerMore ExecutivesKey CompetitorsPremierNASDAQ:PINCSotera HealthNASDAQ:SHCProgynyNASDAQ:PGNYOwens & MinorNYSE:OMINewAmsterdam PharmaNASDAQ:NAMSView All CompetitorsInsiders & InstitutionsNomura Holdings Inc.Bought 24,600 shares on 3/27/2024Ownership: 0.006%Vanguard Group Inc.Bought 220,986 shares on 3/11/2024Ownership: 6.978%Wellington Management Group LLPBought 1,191,253 shares on 3/5/2024Ownership: 10.380%Neo Ivy Capital ManagementBought 3,753 shares on 2/26/2024Ownership: 0.001%Public Employees Retirement System of OhioBought 3,325 shares on 2/16/2024Ownership: 0.030%View All Insider TransactionsView All Institutional Transactions AGL Stock Analysis - Frequently Asked Questions Should I buy or sell agilon health stock right now? 16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for agilon health in the last year. There are currently 1 sell rating, 11 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" AGL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AGL, but not buy additional shares or sell existing shares. View AGL analyst ratings or view top-rated stocks. What is agilon health's stock price target for 2024? 16 brokers have issued 1-year price targets for agilon health's shares. Their AGL share price targets range from $5.00 to $18.00. On average, they expect the company's stock price to reach $9.73 in the next twelve months. This suggests a possible upside of 59.7% from the stock's current price. View analysts price targets for AGL or view top-rated stocks among Wall Street analysts. How have AGL shares performed in 2024? agilon health's stock was trading at $12.55 at the beginning of 2024. Since then, AGL stock has decreased by 51.4% and is now trading at $6.0950. View the best growth stocks for 2024 here. When is agilon health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our AGL earnings forecast. How were agilon health's earnings last quarter? agilon health, inc. (NYSE:AGL) announced its earnings results on Tuesday, February, 27th. The company reported ($0.41) earnings per share for the quarter, missing analysts' consensus estimates of ($0.28) by $0.13. The business earned $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. agilon health had a negative trailing twelve-month return on equity of 21.74% and a negative net margin of 5.76%. The business's revenue was up 71.8% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.14) EPS. Is agilon health a good dividend stock? agilon health (NYSE:AGL) pays an annual dividend of $1.80 per share and currently has a dividend yield of 0.00%. What ETFs hold agilon health's stock? ETFs with the largest weight of agilon health (NYSE:AGL) stock in their portfolio include SPDR S&P Health Care Services ETF (XHS), iShares U.S. Healthcare Providers ETF (IHF), Renaissance IPO ETF (IPO), Fidelity Disruptive Medicine ETF (FMED), Fidelity Fundamental Large Cap Growth ETF (FGRO) and Global X Aging Population ETF (AGNG).RiverNorth Patriot ETF (FLDZ) and What guidance has agilon health issued on next quarter's earnings? agilon health issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.4 billion-$6.5 billion, compared to the consensus revenue estimate of $6.3 billion. When did agilon health IPO? agilon health (AGL) raised $1 billion in an IPO on Thursday, April 15th 2021. The company issued 46,600,000 shares at a price of $20.00-$23.00 per share. J.P. Morgan, Goldman Sachs, BofA Securities, Deutsche Bank Securities and Wells Fargo Securities served as the underwriters for the IPO and William Blair, Truist Securities and Nomura were co-managers. Who are agilon health's major shareholders? agilon health's stock is owned by many different retail and institutional investors. Top institutional shareholders include Capital World Investors (13.60%), Wellington Management Group LLP (10.38%), Vanguard Group Inc. (7.04%), Vanguard Group Inc. (6.98%), Capital Research Global Investors (3.60%) and Capital International Investors (2.69%). Insiders that own company stock include Benjamin Kornitzer, Benjamin Shaker, Cd&R Investment Associates Ix,, Clay Richards, Glenn Sobotka, Jeffrey A Schwaneke, Joan Danieley, John William Wulf, Michael L Smith, Steven Sell, Theodore Halkias, Timothy Gertsch and Veeral Desai. View institutional ownership trends. How do I buy shares of agilon health? Shares of AGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:AGL) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeTop Project Outperforms BTC in 2023…Crypto 101 Media“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryFed launches fourth dollar overhaulStansberry ResearchThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyMost important medical advance in 100 yearsThe Oxford ClubThe 3rd Revolution in WarfareWeiss RatingsWARNING - this content may be disturbingParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding agilon health, inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.